GEMMs were utilized by Kalamarides et al. to demonstrate that the excision of NF2 exon 2 in arachnoïdal cells is rate-limiting for meningioma development in mice where 30% of mice developed meningiomas [180]. This evidence concerns the gene NF2 and meningioma.